Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinsons Disease
December 05, 2025 21:00 ET | Source: Cerevance, Inc. Phase 2 results…
Averna and Spherea Join Forces to Build a Leading Test & Quality Engineering Systems Integration Organization
Together, they set the New Global Standard for Test and Quality Engineering…
Over HK$100 Million Donated by Multiple Web3 FinTech Companies to Support Fire Victims
HONG KONG, Nov. 29, 2025 /PRNewswire/ -- On November 26, a severe Level-5…
CCTV+: Driving Low-Carbon Mining: How Breton’s Autonomous Electric Mining Trucks Strengthen ESG Performance
BEIJING, Nov. 28, 2025 /PRNewswire/ -- Breton Technology unveiled its latest generation of…
Pullman and Novotel New Delhi Aerocity Celebrate 10 years of Excellence
Marking ten years of elevating experiences, shaping culinary culture and leading Aerocity's…
The GameFi-cation of Trading: Fortuva Announces New Update Blurring the Line Between Markets and Gaming
TAMPA, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Fortuva today announced a…
LINGLONG TIRE TIPS OFF NEW JOURNEY WITH CHICAGO BULLS
Partnership underscores Chicago Bulls' global reach and resonance and reflects Linglong Tire's…
DHL boosts operational efficiency and customer communications with HappyRobots AI Agents
San Francisco, Nov. 25, 2025 (GLOBE NEWSWIRE) -- DHL Group, the world’s…
Alzheimer’s Association Statement on Oral Semaglutide Phase 3 Topline Data Release
- Results Underscore Need for Continued Research and Diverse Treatment PipelineCHICAGO, Nov.…
GAC Unveils “Four Growth Engines,” Reforging a New GAC at 2025 Guangzhou Auto Show
GUANGZHOU, China, Nov. 21, 2025 /PRNewswire/ -- On November 21, the 23rd Guangzhou…